| Clinical outcomes for patients with metastatic renal cell carcinoma treated with alternative sunitinib schedules BJ Atkinson, S Kalra, X Wang, T Bathala, P Corn, NM Tannir, E Jonasch The Journal of urology 191 (3), 611-618, 2014 | 140 | 2014 |
| Cancer immunotherapy: sipuleucel‐T and beyond AE Hammerstrom, DH Cauley, BJ Atkinson, P Sharma Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (8 …, 2011 | 130 | 2011 |
| Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome BJ Atkinson, RE Lewis, DP Kontoyiannis Sabouraudia 46 (6), 541-546, 2008 | 115 | 2008 |
| Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases S Kalra, BJ Atkinson, MR Matrana, SF Matin, CG Wood, JA Karam, ... BJU international 117 (5), 761-765, 2016 | 80 | 2016 |
| The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients S Yennurajalingam, B Atkinson, J Masterson, D Hui, D Urbauer, SM Tu, ... Journal of palliative medicine 15 (1), 20-24, 2012 | 78 | 2012 |
| Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma JP Reddy, M Hernandez, JR Gunther, BS Dabaja, GV Martin, W Jiang, ... British journal of haematology 180 (4), 545-549, 2018 | 55 | 2018 |
| Mammalian target of rapamycin (mTOR) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: Predictors, management, and outcomes BJ Atkinson, DH Cauley, C Ng, RE Millikan, L Xiao, P Corn, E Jonasch, ... BJU international 113 (3), 376-382, 2014 | 48 | 2014 |
| Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experience AV Shetty, MR Matrana, BJ Atkinson, AL Flaherty, E Jonasch, NM Tannir Clinical genitourinary cancer 12 (5), 348-353, 2014 | 44 | 2014 |
| High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer AR Wolfe, RL Atkinson, JP Reddy, BG Debeb, R Larson, L Li, H Masuda, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 1072-1080, 2015 | 43 | 2015 |
| Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies MR Matrana, C Duran, A Shetty, L Xiao, BJ Atkinson, P Corn, LC Pagliaro, ... European Journal of Cancer 49 (15), 3169-3175, 2013 | 38 | 2013 |
| Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions S Chowdhury, MR Matrana, C Tsang, B Atkinson, TK Choueiri, NM Tannir Hematology/Oncology Clinics 25 (4), 853-869, 2011 | 34 | 2011 |
| Impact of statin use on outcomes in triple negative breast cancer SF Shaitelman, MC Stauder, P Allen, S Reddy, S Lakoski, B Atkinson, ... Journal of Cancer 8 (11), 2026, 2017 | 32 | 2017 |
| Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre E Jonasch, LS Lal, BJ Atkinson, SDC Byfield, LA Miller, LC Pagliaro, ... BJU international 107 (5), 741-747, 2011 | 30 | 2011 |
| Outcomes of patients with metastatic non–clear-cell renal cell carcinoma treated with pazopanib MR Matrana, A Baiomy, M Campbell, S Alamri, A Shetty, P Teegavarapu, ... Clinical genitourinary cancer 15 (2), e205-e208, 2017 | 26 | 2017 |
| Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency KR Watkins, JE Rogers, B Atkinson Supportive Care in Cancer 23, 1657-1662, 2015 | 25 | 2015 |
| Outcomes of patients with metastatic renal cell carcinoma and bone metastases in the targeted therapy era S Kalra, J Verma, BJ Atkinson, SF Matin, CG Wood, JA Karam, SH Lin, ... Clinical genitourinary cancer 15 (3), 363-370, 2017 | 24 | 2017 |
| Outcomes of unselected patients with metastatic clear‐cell renal cell carcinoma treated with first‐line pazopanib therapy followed by vascular endothelial growth factor … MR Matrana, T Bathala, MT Campbell, C Duran, A Shetty, P Teegavarapu, ... BJU international 118 (2), 264-271, 2016 | 24 | 2016 |
| Implementation of postdischarge follow-up telephone calls at a comprehensive cancer center SD Patel, PA Nguyen, M Bachler, B Atkinson American Journal of Health-System Pharmacy 74 (11_Supplement_2), S42-S46, 2017 | 18 | 2017 |
| Rhabdomyolysis in a prostate cancer patient taking ketoconazole and simvastatin: case report and review of the literature JL Watkins, BJ Atkinson, LC Pagliaro Ann Pharmacother 45 (2), e9, 2011 | 15 | 2011 |
| Emerging targeted therapies in metastatic renal cell carcinoma M R Matrana, B Atkinson, E Jonasch, N M Tannir Current Clinical Pharmacology 6 (3), 189-198, 2011 | 13 | 2011 |
Eric JonaschProfessorVerified email at mdanderson.org
